Literature DB >> 21793920

Cerebral embolic exposure during transfemoral and transapical transcatheter aortic valve replacement.

Wilson Y Szeto1, John G Augoustides, Nimesh D Desai, Patrick Moeller, Michael L McGarvey, Elizabeth Walsh, Amr Bannan, Howard C Herrmann, Joseph E Bavaria.   

Abstract

AIM OF STUDY: To characterize the cerebral embolic exposure during transfemoral (TF) and transapical (TA) TAVR.
METHODS: To detect cerebral embolic events during TAVR, intraoperative neuromonitoring using transcranial Doppler (TCD) was utilized in 28 patients (Edwards SAPIEN valve TF n = 18, TA n = 10). High intensity transient signals (HITS) reflective of embolic events were recorded.
RESULTS: The mean age was 83.4 ± 7.4 years. The Society of Thoracic Surgeons predicted risk of mortality score was 11.7 ± 2.9. The total number of HITS during TAVR was not significantly different between the TF and the TA groups, respectively (375 ± 301, 440 ± 283, p = 0.58). The highest number of HITS occurred during wire manipulation in the arch and valve insertion (TF, 80 ± 110, 107 ± 81; TA, 120 ± 80, 92 ± 80). In the TF group only, severe arch calcification was associated with significantly higher number of HITS both in total number of HITS (Grade I/II, 278 ± 71; Grade III/IV, 568 ± 479, p = 0.05) and during wire manipulation in the arch and valve insertion (Grade I/II, 140 ± 46, Grade III/IV 294 ± 239, p = 0.04).
CONCLUSIONS: Highest cerebral embolic exposure occurred during wire manipulation in the arch and valve insertion in both the TF and TA groups. Arch calcification appears to be associated with increased embolic risk, specifically in the TF approach. Understanding of the mechanism of cerebral embolism is needed for future strategies of cerebral protection during TAVR.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21793920     DOI: 10.1111/j.1540-8191.2011.01265.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  11 in total

Review 1.  TAVI 2012: state of the art.

Authors:  Jochen Reinöhl; Constantin von Zur Mühlen; Martin Moser; Stefan Sorg; Christoph Bode; Manfred Zehender
Journal:  J Thromb Thrombolysis       Date:  2013-05       Impact factor: 2.300

Review 2.  Incidence, predictors, origin and prevention of early and late neurological events after transcatheter aortic valve implantation (TAVI): a comprehensive review of current data.

Authors:  Philipp Kahlert; Fadi Al-Rashid; Björn Plicht; Heike Hildebrandt; Polykarpos Patsalis; Karim El Chilali; Daniel Wendt; Matthias Thielmann; Lars Bergmann; Eva Kottenberg; Marc Schlamann; Holger Eggebrecht; Heinz Jakob; Gerd Heusch; Thomas Konorza; Raimund Erbel
Journal:  J Thromb Thrombolysis       Date:  2013-05       Impact factor: 2.300

Review 3.  Aortic atherosclerosis and embolic events.

Authors:  Muhamed Saric; Itzhak Kronzon
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

4.  Characteristics of aorto-iliofemoral arterial tree according to aortic valve morphology in chinese patients considered for TAVR.

Authors:  Yuan Wang; Hasan Jilaihawi; Guanyuan Song; Moyang Wang; Bin Lv; Hao Wang; Guannan Niu; Zheng Zhou; Yongjian Wu
Journal:  Int J Cardiovasc Imaging       Date:  2018-02-02       Impact factor: 2.357

Review 5.  Transcatheter aortic valve implantation: current and future approaches.

Authors:  Josep Rodés-Cabau
Journal:  Nat Rev Cardiol       Date:  2011-11-15       Impact factor: 32.419

6.  Development and Application of a Risk Prediction Model for In-Hospital Stroke After Transcatheter Aortic Valve Replacement: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.

Authors:  Vinod H Thourani; Sean M O'Brien; John J Kelly; David J Cohen; Eric D Peterson; Michael J Mack; David M Shahian; Frederick L Grover; John D Carroll; J Matthew Brennan; Jessica Forcillo; Suzanne V Arnold; Sreekanth Vemulapalli; Susan Fitzgerald; David R Holmes; Joseph E Bavaria; Fred H Edwards
Journal:  Ann Thorac Surg       Date:  2018-12-07       Impact factor: 4.330

Review 7.  Adjuvant Antithrombotic Therapy in TAVR.

Authors:  Ryan G O'Malley; Kenneth W Mahaffey; William F Fearon
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

Review 8.  Transcatheter aortic valve implantation.

Authors:  Thomas M Snow; Neil Moat; Sarah Barker; Alison Duncan; Carlo Di Mario
Journal:  Glob Cardiol Sci Pract       Date:  2012-08-30

9.  Thirty-day incidence of stroke after transfemoral transcatheter aortic valve implantation: meta-analysis and mixt-treatment comparison of self-expandable versus balloon-expandable valve prostheses.

Authors:  Philipp C Seppelt; Silvia Mas-Peiro; Roberta De Rosa; Zisis Dimitriasis; Andreas M Zeiher; Mariuca Vasa-Nicotera
Journal:  Clin Res Cardiol       Date:  2020-11-29       Impact factor: 5.460

10.  Stroke following transcatheter aortic valve implantation. Is neuroprotection justified?

Authors:  Maciej Dąbrowski; Adam Witkowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-11-18       Impact factor: 1.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.